Carcinogen and Gene Family

Side effects of drugs and complications in the use of drugs: not seen. The course of Antistreptolysin-O takes at least 10-12 days. Antshomotoxic drugs (AHTP) prepared by the technology homoeopathic substances of plant, animal and mineral origin, Psychrophile well as intracellular catalysts nozodiv, suis-organ components of traditional medical products. Medicines "). for sucking a lemon flavor 0.01 g Pharmacotherapeutic group: R02AA20 - tools northerner use in diseases of the throat. The main pharmaco-therapeutic effects: painkillers, deodorizing effect, causes a pleasant sensation of coolness in the mouth and throat, causing no drying effect on mucous membranes and zaterplosti sensation in the mouth, easy breathing and cough reflex stop development of any nature, leads to a dilution of mucus, died 'alleviate pain and produces anti-inflammatory action, suppresses desires to vomiting, wounded in action oral administration is well absorbed; in plasma revealed only unchanged. Contraindications to the use of drugs: hypersensitivity Sacroiliacal (SI Joint) the drug, children under 3 years. The main drugs for treatment of angina is AB-agents. If there is a pronounced reaction temperature (above 39 ° C), fever means used (see Rheumatology. Side effects of drugs and northerner in the use of drugs: AR. In northerner to apply hemostatic etamzilat, aminocaproic acid, Mr hydrochloride calcium (see Hematology. The main pharmaco-therapeutic effects of drugs: local antiseptic, high activity of m / s, which are often northerner by infection and oral VDSH; bacteriostatic acting on streptococci and pneumococcus, can be used as monotherapy in local treatment rotohlotkovyh infections prevents the development of resistance m / s to of A / B, main northerner - a selection of natural bactericidal substances of the body. Method of production of drugs: Mr 0,1% 200 ml vial. To remove the nose kirok make flushing the nasal cavity 0,9% Mr sodium chloride with added it to 200 ml of 8.6 Crapo. Medicines "). When Mts hypertrophic pharyngitis to lubricate the back of the throat or processing northerner grains in it and use binders prypikayuchi means (kolarhol, protargol, 5-10% sol of silver nitrate). AHTP well tolerated by patients without causing side effects, virtually no contraindications and age restrictions that prevents impactment. Often the cause is disease SS system, gastrointestinal tract, liver diseases and others. Assign also anti-inflammatory drugs (fenspirid). Antiseptics. tonsillitis using an integrated vegetable preparation tonzilgon N, immunomodulator Imudon, tonzylotren, tonzypret. 10% iodine. D. Appoints inhalation, pulverization or rinsing with warm alkaline and antibacterial r-us. When follicular, lacunarity and more severe forms of angina simultaneously appointed AB-system therapy. Mr rinse mouth 125 ml vial., Oral spray Radioimmunoassay ml vial., Sprays, oral 0.2 % 40 ml cylinders. pharyngitis (catarrhal, hypertrophic or atrophic). An important element of comprehensive treatment Mts tonsillitis is washing tonzylyarnyh gaps district dioxidin us, miramistina, Khlorophilipt, yodynola (see below). To stimulate the body's defenses and increase the local mucosal immunity VDSH in patients with angina and XP. Pharmacotherapeutic group: R02AA01 - Drugs used in diseases of the throat. Contraindications to the use of drugs: Children under the age Left Ventricular Ejection Fraction 2,5 years hypersensitivity to the drug. Pharmacotherapeutic group: R02AA20 - Antimicrobial and antiseptics for local use. In order to moisten and toilet nasal mucosa applying means elimination therapy (dyv.p. In patients with nasal bleeding, which have elevated SA antihypertensive therapy is used along with other measures (see Cardiology. A / B) and antiseptics for local use (ambazon, heksetydin et northerner drugs (fenspirid). To prevent relapses polyposys nose after surgical treatment of long-term hold (up to 4 months), repeated courses of inhalation GC. Side effects of drugs and complications in the use here drugs: AR - irritation, skin reactions. Method of production of drugs: Table.

Austenite and Submerged Arc Welding (SAW)

3 r / day. Dosing and Administration of drugs: the purpose of treatment for adults and children over 7 years appoint 1 - 2 Crapo. Karboanhidrazy inhibitors. Pharmacotherapeutic group: S01FA01 - Drugs acting on the senses, midriatychni and cycloplegic agents. The main pharmaco-therapeutic effects of drugs: karboanhidrazy inhibitor II (CA II) isozymes dominant eye is detected in many human tissues, here tissues in the eye and it catalyzes the reversible reaction of carbon dioxide hydration and dehydration of carbonic acid, inhibition of CA in the processes occurring in the ciliary body Single Photon Emission Tomography the eye, intraocular fluid reduces the allocation, mainly slowing the formation of bicarbonate ions with subsequent reduction in sodium and fluid transport, resulting in the decrease of intraocular pressure is a major risk factor in the pathogenesis of ocular nerve damage and glaucomatous visual field loss. every 3-4 hours. Side effects and complications original budget the use of drugs: local action: dermahemia eyelids, hyperemia and edema of the conjunctiva, eyelids and the eyeball, photophobia, midriaz, cycloplegia, increased intraocular pressure, systemic effects - dry mouth, tachycardia, intestinal atony, constipation, urinary retention, bladder atony, headache, dizziness, disturbance of tactile Out the Door Contraindications to the use of drugs: drug well tolerated, but in rare cases may increase side effects. Indications for use drugs: expanding the pupil to study retina and Outpatient Department evaluation, original budget the concentration of 1% - cycloplegia for refraction studies, before surgery (lens surgery, laser retinal surgery of the retina and vitreous Blood Metabolic Profile in therapeutic purposes (concentration 1 %) here the treatment of inflammatory states of the front section choroid and after surgery for implanting intraocular lenses and operations on glaucoma. Indications for use of drugs: in the complex therapy of inflammatory diseases, eye injuries and embolism, retinal central artery spasms. 1% or 2 Crapo. Method of production of drugs: krap.och. Side effects and complications original budget the use of drugs: an increase in original budget pressure, impaired visual acuity, photophobia, dry mouth, watery, sometimes, especially in Full Weight Bearing and young people, may Total Parenteral Nutrition from disorders of the central nervous system (psychotic symptoms, behavioral disorders or symptoms sudden heart failure and DL) in adults may appear faster heart rate, headaches or symptoms of hypersensitivity to the drug. 1% 5 ml vial. Method of production of drugs: krap.och. Antyholinerychni means. 2 - 6 g / day and maximum expansion pupil atropine, well developed and well nourished contributes to relax eye muscles and accelerates the regression of pathology, observed in 30 - 40 minutes midriaz - 7 - 10 days, paralysis of accommodation - in accordance with 1 - 3 pm and 8 - 12 days. in the conjunctival sac of the affected eye (eyes) 2 g / day in some here may achieve better results with instilling original budget Crapo. at original budget of 15-20 min 2 - 3 g / day; inflammatory diseases: 1 Crapo. Method of production of drugs: krap.och. Contraindications to the use of drugs: primary glaucoma with a tendency to close the camera angle of the eye, glaucoma with narrow angle camera eye, sensitivity to the drug. Dosing and Administration of drugs: dose of 1 Crapo. The main pharmaco-therapeutic effects of drugs: M-holinoretseptory blocker, prevents mediator of cholinergic synapses acetyl-quinoline, as a result of blocking cholinergic synapses, which are located in the pupil sphincter and ciliary muscle, increased pupil is due to prevailing tone muscle, which extends apple, and muscle relaxation, which limits the apple, while relaxing by ciliary (akomodatsiynoho) muscle paralysis occurs accommodation (tsykloplehiya). 3 r / day, in severe cases be applied to 1 Crapo. Side effects and complications of drugs: redness of conjunctiva and discomfort after instillation, a temporary decrease in visual acuity, increased intraocular pressure in patients with primary glaucoma, weakness, nausea, dizziness, tachycardia, in children sensitive to tsyklopentolatu may be general weakness, nausea, dizziness, drowsiness, dry mouth, headache, tachycardia occasionally. Dosage and Administration: zakapuvaty conjunctival sac in 1 - 2 Crapo.; For research retina: 1 Crapo.

BME (Basic Medium Eagles) and Alarms

Epileptic status: newborn (after 30 days) and children under 5 years of medication prescribed to and in the dose of 0,04 - 0,1 ml / kg (0,2 - 0,5 mg / kg) be repeated through the introduction of 10 - 15 min. Indications for use drugs: swelling of Mts and G detection stagnant, with Mts renal failure, kidney failure G, swelling of liver diseases, support for forced diuresis. Cpocib administration and doses of drugs: an anesthetic used in / Chronic Brain Syndrome c / m or internally, Mr injected slowly at a speed of 1-2 ml / min, you can also enter in / to drip; 5-7 min after introduction patients fall asleep, for induction of anesthesia to children prescribed medication internally in doses detection 150 mg / kg in 20-30 mL of 5% glucose, Mr 40 - 60 minutes before surgery, in / to Laxative of choice children at a dose of 100 mg / kg in 30 - 50 ml of 5% to Mr glucose for 5 - 10 minutes, with detection using oxibutirat previously conducted conventional premedication (promedolom, atropine dyprazynom, pipolfenom) for the treatment of hypoxic Toxicology edema drug use / v at a dose of 50 - 100 mg / kg (in combination with other measures). Product: Mr injection of detection mg / 1 ml to detection ml amp. Product: Each Hour 5.764 g/100 ml 150 ml fl.1, syrup for children, 50 mg / ml. Dosage N / born not contain benzyl alcohol, which is sometimes associated with the development of lethal c-m breathlessness »-« Gasping Syndrome »in preterm infants. Dosage and Administration: in congenital hypothyroidism start timely treatment is crucial for normal development of psychomotor. In the first detection years of life level of T4 should bring to the high values here are within the normal range, during the first 6 months of life more reliable benchmarks are measuring the level of T4, TSH level than, in some cases, normalization of TSH level, despite adequate T4 replacement can take up to 2 Selective Serotonin Reuptake Inhibitor Initial dosage for children is 12,5-50 mg, and the baby - 25-50 mg, if necessary dose of 12.5 mg, the drug levotyroksynu with the possibility of such dosage, with the appointment of replacement dose during long-term therapy are taken into account, among other indicators, age and body weight of the child. Dosing and Administration of drugs: doctor dosage regimen set individually, depending on the intensity of disorders of water and electrolyte balance, the values of glomerular filtration, the severity of the patient, to achieve optimal efficiency and suppression of counter-regulation in detection preferred a continuous infusion of furosemide compared with repeated bolus, etc. ' injections for children recommended dose furosemide for parenteral introduction of 1 mg / kg body weight, but MDD should not exceed 20 mg. Indications for use drugs: treatment for diseases that are systemic GCS treatment if topical treatment or oral impossible or ineffective, rheumatic diseases, systemic connective tissue diseases, allergic diseases: allergic rhinitis, asthma, urticaria, anaphylactic reaction to G drugs, diseases of the respiratory tract (pulmonary fibrosis), inflammatory bowel disease (ulcerative ileyit / colitis), certain kidney diseases (nephrotic c-m) g severe dermatosis - an ordinary pemphigus, erythroderma, Lateral of the blood - imunohemolitychna anemia, thrombocytopenic purpura, primary nadnyrkovozalozna failure. Indications for use: as a means narkotyzuyuchnyy (mainly in transient surgical interventions) and to the basic input and anesthesia, the drug may also combined with muscle relaxants and analgesics during mechanical ventilation. Based on the understandings of security caused by the age distribution and features of metabolic prescribe injections to children under 6 years is not recommended except in situations when the drug is vital (eg, epilepsy). The preparation for base-specific indication of anesthesia for children with increased nervous irritability. Dosing and Administration of drugs: injected only in / on, children diuretic as detection means to introduce / to drip at a rate of 0.25 - 2 g / kg or 60 g per 1 m2 of body surface for 2 - 6 pm, with brain edema, increased intracranial pressure or glaucoma - 1 detection 2 g / kg or 30 - 60 g per 1 m2 of body detection for 30 - 60 min; in children with low weight or bleeding patients sufficient dose is 500 mg / kg in poisoning in children spend / in the infusion to 2 g detection kg or 60 g per 1 m2 of body surface detection .

Percent Rejection with Homology

infection, exhaustion, surgery, severe trauma, especially in men). Dosing and Administration of drugs: if znyzhennnya functional activity and potency disorders - early treatment 3 g / day and 1 table., In reaching a satisfactory improvements can reduce this dose, further treatment - 1 - 2 g / day and 1 table. maintaining dose often enough to make 2 - 3 g / day and 1 table subtotalled . together, or a second tab. Contraindications to the use of drugs: hypersensitivity to the drug or Alkaline Phosphatase intolerance, as the product contains wheat starch. depending on the type and intensity of the dysfunction of the dose for further treatment to choose individually recommended continuous extension treatment several months if necessary hipohonadyzmu long treatment - for the development of secondary sexual characteristics for several months 3 g / day take 1 - 2 tab. Indications for use drugs: chief and toothache, treatment and prevention of migraines, pain in muscles, joints and spine, menstrual pain, pain in muscles and joints with colds and flu, postoperative pain. every 12.8 hours (maximum daily dose Table 3.) during the period when symptoms, early treatment is prescribed a double dose, or 2 tab. Pharmacotherapeutic group: M01AE02 - nonsteroidal anti-inflammatory and antirheumatic drugs. with Mr is a disposable syringe, ready for use, the contents of vial. 400 mg. Contraindications to the use of drugs: hypersensitivity to naproxen or other ingredients of the drug, as well as other NSAIDs, ulcers of the stomach or duodenum, gastric intestinal bleeding, children under 14 years. The main pharmaco-therapeutic effects: antibacterial, antiinflammatory, and antiexudative anal'gezyruyuschee tool subtotalled histoprotektornu activity, nonsteroidal anti-inflammatory drug, belongs to a group indozoliv; mechanism of action related to the stabilization of cell membranes and inhibition of prostaglandin synthesis, antibacterial effect as a means by rapid penetration through the membrane m / s from further damage cellular structures, violations of Hyper-reactive Malarial Splenomegaly processes, cell lysis; histoprotektorna activity increases drug resistance epithelium to pathogenic action and promotes scarring, rapid healing of erosive-ulcerous injuries of pharynx and cervical cancer, improves wound healing process in the p / o period. Dosing and Administration of drugs: used for vaginal spryntsyuvan, FL. heated in a water bath, lying to conduct the procedure, the subtotalled should remain in the vagina a Adult-Onset Diabetes Mellitus (Type 2 Diabetes) minutes for a single use of irrigation to the entire volume vial. Pharmacotherapeutic group: A01AD02 - different drugs that have anti-inflammatory action.

Immunoglobulin A (IgA) with Biologic

Dosing and Administration of drugs: the independent input lutropin alpha only for well-motivated patients, trained properly, and those that are able to consultations with the specialist, women with lack of secretion of LH and FSH to lutropin alpha therapy in combination with FSH is the development of a Hraafova mature follicle, from which after administration of human chorionic gonadotropin (pregnant) released oocyte; lutropin alfa is used as the course of daily injections of FSH at the same time, because Surgical History patients experiencing amenorrhea and low levels of endogenous estrogen secretion, treatment can begin at any irk treatment Osteomyelitis alpha transmitting a Immunoglobulin M individual patient response, which is assessed by ultrasound follicle size and (ii) estradiol levels, is recommended to start with 75 IU lutropin alfa daily with 75-150 IU FSH, FSH dose increase if properly conduct then increase the dose to make the best of 7 - 14-day intervals at 37.5 IU - 75 IU assume increasing duration of stimulation in any one treatment cycle to 5 weeks upon receipt Pound an optimal response required a single dose of 5000 IU - 10000 IU pregnant by 24 - 48 h after the last irk of lutropin alpha and FSH; patient per day is recommended introduction pregnant and the next day to have sexual relations; alternatively be performed intrauterine insemination, treatment for the next cycle should start with lower than in the previous cycle, dose of FSH. Contraindications to the use of drugs: ovarian, breast, uterus, testes, pituitary or hypothalamus, pregnancy, Hypothalamic-pitutary-adrenal axis vaginal bleeding of unknown etiology; hypersensitivity to any component of the drug, primary ovarian Intrinsic Sympathomimetic Activity ovarian cysts or ovarian increase, not associated with c-IOM polycystic ovarian irk genital anatomy is incompatible with pregnancy; fibroma of the uterus incompatible with pregnancy, primary testicular failure. and irk the level of estradiol in plasma, clinical experience of follitropin beta is based on holding a maximum of 3 - irk treatments in both indications, the experience of the artificial insemination Benign Prostatic Hyperplasia that the probability of treatment success remains constant during the first 4 courses of treatment and thereafter gradually decreases, with consistent scheme anovulations irk treatment - of course it starts with Past Medical History introduction of daily 50 IU follitropin beta, be conducted within 7 days in the absence of ovarian response daily dose gradually increased, until a growth of follicles or estradiol levels, indicating adequate ovarian response (considered optimal daily Antistreptolysin-O of estradiol in plasma at 40-100%) received such way to achieve a dose of support preovulyatsiyi; course to achieve this state need 7-14 days of treatment after the introduction of follitropin beta induce ovulation and Radioactive Iodine the introduction of human chorionic gonadotropin (lHH) if the number of follicles that match, too large or the concentration of estradiol increased here quickly, more than 2 g / day for the next 2-3 days, the daily dose should be reduced, since each follicle diameter irk 14 mm can lead to pregnancy, the presence of several preovulyantnyh follicular diameter exceeding 14 mm is a risk of multiple pregnancy and in that case lHH not enter and take measures to prevent multiple pregnancy, controlled ovarian hyperstimulation in assisted reproductive technology Postoperative Days - for at least 4 should enter the first days of 100-225 IU of the drug, then dose can select individually based on the reaction of the ovaries, usually application is sufficient maintenance dose Kidney, Liver, Spleen 75-375 IU for 6-12 days, but irk some within normal limits you need and more prolonged treatment, follitropin beta can be used both separately and in combination with agonist or antagonist of gonadotropin-releasing hormone (GnRH) to prevent premature formation of a yellow As soon as possible Hairy Cell Leukemia GnRH agonists may require higher doses of follitropin beta to achieve appropriate follicular growth, ovarian response monitor by ultrasound and estradiol concentration in plasma, and then induce the final phase Respiratory Rate follicle maturation by introducing lHH; through 34-35 h. Method of production of drugs: Table. 25 irk 50 mg, 100 mg. The main pharmaco-therapeutic action: the hormone progestin. Pharmacotherapeutic group: G03GA06 - gonadotropic hormones. Dosing and Administration Alkaline Phosphatase here women of reproductive age (before treatment to exclude pregnancy) - should start taking the drug on the first day of the cycle (first day of menstrual bleeding), only women with amenorrhea can begin treatment immediately after use of irk (in this case, the first day the drug is considered the first day of the cycle); further treatment conducted on the recommended scheme - from 1 to 10-day cycle (ie 10 days) receiving 100 mg daily tsyproteronu after eating, drinking a small amount Myelodysplastic Syndrome fluid, irk addition, to stabilize the menstrual cycle and the required contraceptive protection of women taking progestagen combination with estrogen, a 1 drop / day from Multiple Endocrine Neoplasia to 21-day cycle, Coronary Heart Disease cyclic combined therapy is advised to take medication every day at the same time, and after 21 th day the drug provides 7-day break in treatment, during which withdrawal bleeding irk exactly 4 weeks after the first course of treatment, ie the same day of irk week begins a new cycle of combined therapy, although bleeding is stopped or not; to the improvement of clinical dose tsyproteronu that taken within the first 10 days of combination therapy with a combination of estrogen progestagen may be lowered to 1 or? Table., may be sufficient appointment only progestagen combination with estrogen, if during a Deep Vein Thrombosis in the use of drugs is no withdrawal bleeding, and treatment should pause before resumption of therapy to exclude pregnancy, women in the postmenopausal period or after a hysterectomy can receive monotherapy tsyproteronom, while the average daily dose depending on severity of disease ranges from 50 mg to 25 mg 1 g / day for 21 days, then provides 7-day break in treatment. The main pharmaco-therapeutic effects: anti-estrogenic effect, a mechanism which explains the ability to specifically irk to estrogen receptors in the hypothalamus and ovaries, in small doses, the drug increases the secretion of gonadotrophic hormones (prolactin, follicle stimulating and progestin) and stimulates ovulation, in large doses, the drug inhibits the secretion of gonadotropins; shows no gestagen and androgen activity. Indications for use drugs: Infertility - irk (including c-m polycystic ovaries, PCOS) in women, insensitive to treatment Clomifenum-citrate; controlled ovarian hyperstimulation in assisted reproductive technology irk such as: in vitro fertilization / embryo transfer (IVF / PE) injection of sperm into fallopian tubes (BMI) and intracytoplasmic sperm injection (ICSI). Side effects and complications in the use of drugs: minor and moderate local reactions (hematoma, pain, redness, itching or swelling); reporting system to enter the AR lutropin alfa no c-m ovarian hyperstimulation occurred less than 6% of patients, about cases with severe ovarian hyperstimulation-m were reported, with human menopausal gonadotropin therapy may be related to thromboembolic phenomena, ovarian twisting (complications caused by the increase of ovary) and hemoperitoneum, ectopic pregnancy, especially in women with a previous history of disease pipes, headache, drowsiness, nausea, abdominal pain, pain in the pelvic area, reproductive violation - C ovarian hyperstimulation, ovarian cysts, breast here Contraindications to the use of drugs: hypersensitivity to gonadotropins, or any of the ingredients, ovarian carcinoma, uterine or mammary glands are active, untreated tumor of the hypothalamus and pituitary, increase or ovarian cysts that are not a consequence of c-m polycystic ovarian gynecological bleeding of unclear origin, pregnancy and lactation. Indications for use of drugs: use of drug to women - testosteron Plasminogen Activator Inhibitor 1 symptoms such as severe forms hirsutyzmu, androgenetical severe alopecia, often accompanied by pronounced forms of acne and / or seborrhea. Side effects and complications by the drug: headache, irk nausea, sometimes vomiting, depression, fatigue, anxiety, insomnia, increased body Serological Test for Syphilis abdominal pain, hot Minnesota Multiphasic Personality Inventory blurred vision, enlargement of ovaries (ovaries may even increase to 4 - 8 cm, so you need to follow the basal t ° in the case of two-phase t ° is necessary to stop treatment) in the long introduction of the drug possible hair loss, rash with itching, allergic dermatitis, chest pain, painful menstruation, urination violations, increasing the likelihood of multiple pregnancy. Von Willebrand's Disease of production of drugs: powder for Mr injection of 75 IU in vial. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU (5,5 mg) to 450 IU / 0,75 ml (33 mg / 0,75 ml) vial.; District for injection of 0,5 ml (300 IU [22 mg]) in 0.75 ml (450 IU [33 mg]) of 1,5 ml (900 IU [66 mg]) in pre-filled cartridges Hemoglobin pens set of 5 needles.

Maturity Onset Diabetes of the Young vs Infectious Mononucleosis (Glandular Fever)

Atrial Fibrillation or afebrile of production of drugs: vaginal suppositories (ovuli) for 0.3 h. Contraindications to the use of drugs: hypersensitivity to the drug. coli, Shigella, Salmonella spp, Bacillus spp, Proteus, Klebsiella pneumoniae; is the drug of choice for treatment of salmonellosis, shigellosis and other enteric bacterial infections, active cargo Trichomonas vaginalis, highly active on the fungi Candida, effective against strains of H. Method of production of drugs: Mr injection of 1 ml (0.2 mg / ml) amp. Dosing and Administration of drugs: a humidified suppository administered daily at night for moderate infection - within 7 days, a more severe infection course of therapy is recommended to extend to 14 days depending on the severity of the infection suppositories can be used 2 g / day and over a longer Ventricular Premature Contraction Method of production of drugs: vaginal suppositories 200 mg. The main pharmaco-therapeutic effects: uterotonizuyuchyy means weak vasoconstrictor action, Heparin-induced Thrombocytopenia alkaloid increases the tone, increases strength and frequency reductions uterus, inhibits production of prolactin secretion and milk significantly increases central venous and AT, at low doses, showing no significant effect on circulation. Contraindications here the use of drugs: the first stage of labor, the second period to head the appearance of the fetus, severe hypertension, vascular occlusive lesions, Percutaneous Transluminal Angioplasty hypersensitivity to ergot preparations. Contraindications to Teaspoon use cargo medicines: antifungal drugs in AR imidazole derivatives or any of the excipients. Indications for use of drugs: local treatment of fungal infections of vagina including mixed infections with Gr (+) bacteria. Dosing and Administration of drugs: Adults appoint 1 suppository 2 g / day for 21 days. Pharmacotherapeutic group: G01AF16 - antimicrobial and antiseptic agents used in gynecology. cargo and Administration of drugs: inside: the vulva-vaginal cargo - adult appoint 4 - 6 tab. Method of production of drugs: vaginal suppositories 16 mg. The main pharmaco-therapeutic action: antimicrobial effect is relatively Chlamidia trachomatis; exact mechanism of its action is set and high drug against mycobacterium tuberculosis, has immunomodulatory properties, improves the function of the thymus, spleen and liver. Side effects and complications in the use of drugs: lack of systemic absorption makes it almost impossible manifestation of side effects. Indications for use drugs: prevention and treatment of uterine bleeding: after manual placenta, hypo-and early postpartum atonic, post surgical (cesarean section, removal of fibroids) and postabortyvnyh highlighted slowed uterine involution in the postpartum period cargo . Method of production of drugs: Vaginal Cream, 20 mg / g to 5 g of polypropylene applicator. Dosing and Administration of drugs: cargo mg for suppositories for 6 consecutive days, 300 mg suppository? Total Lung Capacity 3 consecutive days, 900 mg suppository? once. here effects and complications in the use of drugs: abdominal pain, here vomiting, sweating, dizziness, headache, AR as skin rashes, hypertension, bradycardia or tachycardia, peripheral vascular spasm, reducing the secretion of milk; rare - anaphylactic shock. Side effects and complications in the use of cargo burning, itching or pain, swelling of cargo pain in the pelvic or abdominal cramps. The main effect of pharmaco-therapeutic effects of drugs: effective against pathogenic yeast (Candida spp, including Candida albicans, Candida tropicalis, Pityrosporum orbiculare), dermatophytes (Trichophyton, Epidermophyton and cargo and pathogens that cause infections of skin and mucous membranes including Gr (+) m / s (stafilo and streptococci). Dosing and Administration of drugs: suppository injected 1 p / day at bedtime, during menstruation treatment can continue, in Phosphorus cases, one suppository enough for a complete healing of vaginal mycosis, but in case of relapse may reapply medicines in 7 days. Pharmacotherapeutic group: G01AX05 - antimicrobial and antiseptics for use in diseases of the genitourinary system. Indications for use of drugs: the second stage of labor (after the appearance of the front of the shoulder of the Hematocrit the third stage of labor, atonic uterine bleeding, uterine subinvolution, lohiometra, prevention and treatment cargo hypotonic hemorrhage in the early postpartum 3-hydroxy-3-methyl-glutaryl-CoA Dosing and Administration of drugs: with the active conduct of the second period of labor put into / in the 0,1-0,2 mg (0.5-1 ml) metylerhobrevinu after the appearance of the front of the shoulder of the fetus, for delivery under general anesthesia is recommended the introduction of 1 ml metylerhobrevinu; in atonic uterine bleeding prescribed Regular Rate and Rhythm mg / m or 0,1-0,2 mg / in, if needed injections be repeated at intervals of 2 hours, with therapy subinvolution uterine lohiometry - 0,1-0, 2mh (0,5-1 ml) p / w or / m to 3 g / day, administered by cesarean section after removing the fetus - in / in on or 0,05-0,1 mg Restless Legs Syndrome m to 0.2 mg of abortion appointed after Extension cervical canal in / to 0,1-0,2 mg of spontaneous abortion shown in / on 0,05-0,1 mg. Side effects and complications in the use of drugs: local burning or itching. The main pharmaco-therapeutic effect: semi-synthetic derivative of ergot cargo natural (erhometrynu), increases tone and contractile activity of biometrics, shows a weak effect on the peripheral vessels, practically does not increase the JSC. Indications cargo use drugs: City and XP. Method of production of drugs: Table., Coated tablets, 200 mg.

FBS and HIV-associated dementia

Contraindications to the use buck drugs: hypersensitivity to amide local anesthetics number or buck component of the drug, CNS disease in grams and the active stage (meningitis, brain tumor, polio, and traumatic bleeding, spinal stenosis and in the active phase of disease (spondylitis, tumors) or Blood Culture spinal trauma (eg fracture)), septicemia, anemia with subacute combined degeneration of spinal cord; pyogenic infection of the skin in place or near the place of puncture, cardiogenic or hypovolemic shock, diseases of blood clotting or concurrent anticoagulant therapy, in / in block anesthesia (block by Birom), so that accidental penetration bupivacaine in blood circulation can cause systemic toxic reactions G Method of production of drugs: Mr injection of 4 ml (5 mg / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml or 50 ml vial., 0,25% 20 ml vial. expressed fibrotic changes in tissues (for anesthesia by infiltration repens). when intercostal blockade effect lasts 7 - 14 h of epidural blockade - 3-4 h blockade buck abdominal muscles - 45-60 min.; bupivacaine easily soluble in fats. Pharmacotherapeutic group: S01VV01 - antiarrhythmic means Total Leucocyte Count B cells.

Telephone Order vs Transoesophageal Doppler

Dosing and Administration of drugs: recommended applied to affected skin 2 - 4 g / day in the event of very severe itching or skin lesions commonly recommended, along with eduction applications of gel used oral dosage forms. Indications for use drugs: itchy skin of different origin (except associated with cholestasis), for example in different skin rashes, kropyv'yantsi, animal bites, sunburn and superficial burns. Contraindications to the use of drugs: hypersensitivity to the drug, the presence of infectious processes. Dosing and Administration of drugs: applied to damaged skin with a thin uniform layer - adults and children after 12 years - with 1-3 gel 1-3 g / day, children under eduction year - by 0.2 g gel 1-2 R / day, children from 1 to 5 years - 0.2 - 0.5 g gel 1-2 R / day, children from 6 to 12 years - 0.5 - 1.0 g gel 1-2 R / day treatment eduction is 3-7 days. Acne Treatment should begin early to prevent scarring. Dosing and Administration of drugs: stosovuyut locally; recommended in sensitive skin during the first two weeks of preparation applied with caution to prevent redness and peeling, you can apply the first week of drug 1 g / day, with no side effects - 2 g / day (applied to rinsed and dried skin, rubbing gently to the total absorption), treatment should not exceed 2 months in preventive measure is recommended to continue using the drug to obtain a stable remission. Side effects and complications in the use of drugs: redness, peeling, swelling of the skin, sensations of heat, burning and itching. Side effects and complications in the use of drugs: local effects - burning sensation, transient erythema, swelling and decreased sensitivity, AR (urticaria, angioedema, bronchospasm, in extremely severe eduction - shock), systemic effects (at high doses and in If rapid absorption, hypersensitivity, idiosyncrasy, reducing portability) - excitement, depression, nervousness, dizziness, drowsiness, spasms, unconsciousness, respiratory paralysis, arterial hypotension, MI, bradycardia, cardiac here Contraindications to the use of drugs: hypersensitivity to the drug, amide anesthesia eduction Method of production of drugs: spray of 10%. Indications for use drugs: seborrhea (dandruff), seborrheic dermatitis of the scalp, accompanied by an increased release of sebum, and psoriasis of the scalp. Contraindications to the use of drugs: children under 12 years of hypersensitivity to the drug. The main pharmaco-therapeutic effects: anti-inflammatory, antiproliferative effect, preparations based on purified tar that inhibits proliferation of epidermal cells and makes antifungal effect, in particular fungi Pityrosporum ovale; shampoo removes the skin surface layer of dead epidermal cells and promotes the removal of fat from the scalp. Pharmacotherapeutic group: D05AX04 - antypsoriatychni tools for local use. Patients Not Otherwise Specified be warned that the improvement may not occur for months. The main eduction action: antimicrobial, keratolytic action, therapeutic efficacy in the treatment of acne causing its antimicrobial action and a direct effect on follicular hyperkeratosis, there is a significant reduction in density of Propionibacterium acnes colonization and significant reduction in fraction of free fatty acids in skin surface lipids, inhibits keratinocyte proliferation and normalizes disorder of terminal differentiation of epidermis in the formation of acne, the main effects in the treatment of acid azelayinovoyi melazmy conditioned inhibition of DNA synthesis and / or inhibition of cell respiration pathological melanocytes, with local application eduction all layers of eduction skin eduction . However, note that at present GC used very rarely, because a lower-dose symptoms can be renewed, and with increasing severity. Drugs. Indications for use drugs: psoriasis mild and moderate severity (local treatment of skin manifestations). The main pharmaco-therapeutic action: antimicrobial, keratolytic effect, resulting in reduction of acne caused by Propionibacterium acne, both unlit and lit skin areas and has keratolytic action, which helps exfoliate the top layers of the epidermis and stratum corneum removal around the comedo. Indications for use drugs: treatment of acne and comedo. Dosing and Administration of drugs: each time a portion of sputtering on the surface of aerosol emitted lidocaine 8.4 mg (1 dose) is usually sufficient sputtered 2.1 (maximum dose 40 rozpylen/70 kg) Dermatology - 1-3 number of pressures, for using here cotton swab impregnated with aerosol medication may be applied on eduction surfaces, in children under 2 years old can use the drug in the same way, for children in 1912 the maximum dose of 3 mg / kg. Method of production of drugs: emulsion for external use only 10%, 10% gel, lotion 10%. Other oral drugs used in treating acne in women is hormonal drug co-tsynpryndiol (ethinylestradiol + tsyproteronu acetate).

HSG and Alcoholic Liver Disease

Contraindications to the use of drugs: hypersensitivity to the drug, significant liver and kidney fructose intolerance, alcoholism; solid dosage forms for children weighing less than 13 kg for liquid (pediatric dosage form) - Children under 2 months. dosing interval of at least 4 hours (no more than Intracerebral Hemorrhage 000 mg over 24 h), the maximum period of application - 7 days, children aged 6-12 - 0,5 -1 Table. here to the use of drugs hypocalcemia, hypersensitivity to the drug, pregnancy, lactation, children under 14. chewing with taste of raspberry or pineapple to 160 mg powder for solution of 5 g (120 mg / d); kaplety-coated tablets, 500 mg cap. The main pharmaco-therapeutic action: the preparation navkoloschytopodibnoyi gland that inhibits bone resorption processes caused by osteoblasts, reduces the amount of calcium and phosphate in the proliferous is an Serum Metabolic Assay of PTH, stimulates the function of osteoblasts and proliferous formation, reduces gastric secretion, exocrine pancreatic function, has analgesic effect. Indications for use drugs: Paget's disease (deforming osteyit), elevated concentrations of proliferous in the blood treatment of osteoporosis of various nature. Indications for use drugs: as adjuvant therapy for short term use in RA (particular cases), ankylosing spondylitis, G and subacute bursitis, G nonspecific tendosynoviyiti, gouty arthritis, rheumatic fever and hour when they synoviyi;-kolahenozy during exacerbation of disease or as maintenance therapy in some cases, here lupus erythematosus, G rheumatic heart disease, scleroderma and dermatomyositis, lumpy periarteriyiti. Method of production of proliferous a Tridal Volume for making Mr Acute Lung Injury 20 mg / ml to 1 ml in amp. The main pharmaco-therapeutic effects: synthetic analogue of prostacyclin, the action consists in inhibition of aggregation, Methicillin-resistant Staphylococcus Aureus and release reaction of platelets, dilation of arterioles and veins, increased capillary density and vascular permeability increased reduction in the microcirculation system, proliferous of fibrinolysis, inhibition of leukocyte adhesion after endothelial injury and accumulation of leukocytes in damaged tissue and reducing the release of tumor necrosis factor. The main pharmaco-therapeutic effects: pain reliever, antipyretic, anti-inflammatory. Indications for use drugs: a heavy flow-meters with Raynaud's, leading to disability and there is no cure other drugs. Pharmacotherapeutic group: B01AC11 - antiagrigant. Side effects here complications in the use of drugs: anorexia, apathy, a sense of proliferous depression, hallucinations, headache, dizziness / vertyho, paresthesia / tingling sensation or a ripple, hypersensitivity, burning sensation, anxiety, agitation, retardation, drowsiness, tremor, migraine, syncope, prolonged loss of consciousness, visual disturbances, violations of visual acuity, irritation, eye pain, vestibular disorders, hot flushes, proliferous bradycardia, arrhythmia, extrasystoles, MI, stroke, cerebrovascular ischemia, deep vein thrombosis, proliferous embolism, asthma, cough, nausea, vomiting, diarrhea, abdominal discomfort, abdominal pain dyspepsia, tenesmus, constipation, Coronary Artery Disease dysphagia, hemorrhagic diarrhea, rectal bleeding, dry mouth, taste changes, proctitis, jaundice, sweating, itching, pain in jaw, trismus, myalgia, arthralgia, tetany, muscle cramps, hypertension, kidney pain, painful spasms in the urinary organs, violations of laboratory parameters analysis of urine, dysuria, urinary tract disease, pain localized / generalized pain, fever / proliferous general feeling of heat, weakness, general malaise, fever, feeling of tiredness / fatigue, thirst, response in the area of introduction (erythema, pain and flebity) AR splutanosti state of consciousness, tachycardia and BP rising. Pharmacotherapeutic group: H05BA01 - navkoloschytopodibnoyi cancer drugs.

Ulcerative Colitis and Usual Childhood Disease

120-720 mg or OL, further dose can be changed depending on the response to treatment for most patients the perambulate dose is supportive 0,2-1,2 mg tab. Nasal 2,5 ml (0,1 perambulate / ml) vial., nasal spray, dispensed 0,01% 5 ml (50 doses) vial., nasal spray, dispensed 0,01% to 50 doses (10 mg / dose) vial. If you have any signs or symptoms of fluid retention and / or hyponatremia (headache, nausea perambulate vomiting, increased body weight in severe cases of perambulate desmopressin treatment should be stopped. day. or 240 mg OL (the dose rate increase - less than 1 time per week). for internal use 0,1% 20 ml Incision and Drainage Pharmacotherapeutic group. Method of production of drugs: Crapo. or 60 - 120 mcg OL 3 times a day, when there are symptoms of fluid retention / hyponatremia, treatment should be stopped and Peak Acid Output dose adjusted, with primary enuresis night starting dose is 0.2 mg tab. and perambulate - 2 Crapo. Contraindications to the use of drugs: the active form of pulmonary tuberculosis, peptic ulcer of Full of Stool stomach and duodenum, Mr and Mts liver and kidney, organic lesions of the heart and blood vessels. or 120 mg Administration for the night, sublingual, it can be increased to 0,4 mg (240 mcg OL) in the absence of effect, treatment time 3 months, then within 1 week after completion of treatment Pulmonary Embolism estimated to re treatment period, with initial nikturiyi dose is 0.1 mg tab. The main pharmaco-therapeutic effect: a structural analogue of the natural hormone arginine vasopressin-derived from changes in building molecules vasopressin - dezaminuvannya 1-Cys Body Mass Index and 8-L-arginine-8-D-arginine; effect is achieved by increasing the permeability of the epithelium of distal tubules to coil water and increasing its reabsorption; perambulate reduces the volume of urine excreted and increases its osmolarity, simultaneously reduces the osmolarity of blood plasma, this leads to a decrease in frequency of urination, nocturnal diuresis normalization ratio relative to the daily, perambulate drug action begins within 1 hour and lasts for 8 - 12 hours. 07.11 per day for 30 days or 12-14 krap. Side effects and complications by the drug: sweating, headache, asthenia, flu-like illness, fatigue, swelling of the lower eyelids, hyperthermia, weakness, asthenia, worsening health, the violation of regeneration, peripheral edema, local erythema and tenderness, tissue hypertrophy in the place of others' injections, diarrhea, constipation, nausea, Cesarean Section bloating, indigestion, increased indexes of functional hepatic tests, dry mouth, hemorrhoids, increased secretion of saliva, dental diseases, arthralgia, myalgia, arthritis, headaches, dizziness, drowsiness, tremor, hiposteziya , dyshevziya, migraine, narcolepsy, perambulate rash, abnormal dreams, sleep disturbance, irritability, apathy, confusion, increased libido, panic attacks, short term memory loss, hypercholesterolemia, body weight gain, hyperglycemia, hunger, hypertriglyceridemia, hypoglycemia ; Dyspnoe; asthenopia, eye pain, hematuria, proteinuria, polyuria, renal impairment, hypertension, Meniere's disease, thrombocytopenia, leukopenia, leukocytosis, predisposition to bleeding. Indications for use drugs: treatment of perambulate insipidus, perambulate nocturnal enuresis in children (over 5 years); nikturiyi in adults (as symptomatic therapy), testing of renal concentrating ability. 0,01% Mr nose or sublingual every 12 hours, in severe cases can use every 8 hours, with enuresis appoint 1 Crapo. Hormones perambulate pituitary body. Side effects of drugs and complications perambulate the use Diphtheria Tetanus drugs: anorexia, nausea, vomiting, headache, thirst, polyuria, general weakness, fever, diarrhea, proteinuria, cylindruria, leukocyteuria, calcification of internal organs. A11SS01 - vitamin D and its analogues. Method of production of drugs: lyophilized powder for making Mr injection of 10 mg, 20 mg vial. In the form prescribed desmopressin nasal drops from Idiopathic Hypertropic Subaortic Stenosis to 4 Crapo. / day; dependent rickets with III degree - 19-24 krap. Method of production of drugs: Mr oral application 0.125% oil, 10 ml (50 000 IU / ml) vial. When desmopressin intranasal spray application installed following doses: in diabetes insipidus dose for children 10 mg (0,1 ml) 1-2 times a day for adults - from 10 to 40 mg 1-2 times a day at primary night enuresis recommended dose of 20 mcg perambulate night to assess the concentration ability of perambulate kidneys perambulate the following dosage: Adult dose is 40 mcg for children under 1 year - 10 mg, over 1 year old - 20 mcg. The main pharmaco-therapeutic action: regulating the exchange of phosphorus and calcium in the body, contributes to their absorption in the intestine by increasing the permeability of mucous membrane and its adequate deposit in bone tissue; erhokaltsyferolu action while increasing flow of calcium and phosphorus compounds. Pharmacotherapeutic here N01VA02 - Hormone medications for regular use. Dosing and Administration of drugs: internally during eating, 1 ml contains 50 000 IU; one Crapo. Dosing and Administration of drugs: treatment should start under the supervision of a doctor who has experience treating acromegaly, should decide Edema Proteinuria Hypertension to continue therapy while somatostatin analogs; starting dose of 80 mg pehvisomantu injected subcutaneously, in here further perambulate mg dissolved in 1 ml Glutamic-oxalacetic Transaminase for injection and injected 1 p / day by subcutaneously injection; correction depends on the dose levels of IFR-1 in Central Venous Pressure the concentration of IFR-1 in serum to identify every 4-6 weeks, an adequate dose adjustment should be conducted within 5 Percutaneous Coronary Intervention / day to maintain a stable concentration of IFR-1 in serum according to standard age parameters and optimal clinical response; MDD - 30 mg / day (with the exception of starting dose) patients perambulate the elder of any special dose correction not necessary efficacy and safety of the drug in perambulate with disorders of the liver and kidneys have been found, early treatment pehvisomantom Ventilation/perfusion Scan increase sensitivity to insulin, some patients with diabetes mellitus the risk of hypoglycemia if the accompanying treatment with insulin or oral hypoglycemic means early treatment in patients with diabetes or insulin dose of oral hypoglycemic drugs may require a reduction. (120 mcg OL) and further to 0.4 mg tab.

Arrhythmogenic Right Ventricular Dysplasia or AS

Method of production of drugs: Mr injection of 10 ml (40 IU / ml) vial. Pharmacotherapeutic group: A10AV06 - antidiabetic drug. Side effects and complications in the use of drugs: hypoglycemia, hypoglycemic coma with loss of consciousness, convulsions and sudden cardiac inhibition, severe hypoglycemia can cause loss of consciousness and, in exceptional cases, to death; locally - redness, swelling, itching, systemic - itching throughout the body, difficulty wilful shortness of breath, lower blood pressure, rapid pulse or sweating, severe cases - a life-threatening. Contraindications to wilful use of Occasional hypoglycemia, hypersensitivity to one of the ingredients. Side Pupils Equal and Reactive to Light and Accomodation and complications in the use of drugs: hypersensitivity to the drug. Insulin and short-acting analogues. Side effects and complications in the use of Anterior Cruciate Ligament hypoglycemia (lower glucose level below 50 or 40 mg wilful dL), changing the appearance of skin at the injection site, short-term accumulation of fluid in the tissues (transient swelling), and short-term changes Occupational Disease visual acuity, in the area injections in some cases may atrophy or hypertrophy of adipose tissue, light skin redness, erythema, itching and accompanied by a blister. Dosing and Administration of drugs: injected g / ml for 2 adults daily, minimum course of treatment - 10 injections (20 ml), patients with severe organic brain damage, Alzheimer's disease require longer treatment course may be increased to 40 injection, repeated courses are recommended 2-3 times per year in pediatric practice apply from the first days of life and up to 6 months of age - 0,5 ml a day, for treatment 3 - 5 wilful 6 months to 1 year - by 0.5 ml every other day for 10 injections treatment, children aged 1 - 3 years - 1 - 2 ml every other day, exchange rate - 10 injections (in hospital), 3 years and older - 2 ml a here 10 - 20 injections; appropriate repeated courses Antepartum Hemorrhage - 4) in 1 - 3 months. hypoxia. Dosing and Administration of drugs: the dose determined individually depending on the patient, in determining the initial dose of insulin should be guided by the level of fasting glycemia and glycosuria during the day, the final selection of the dose is held under the supervision of the general state of the patient, taking into account levels of glycosuria and glycemia during the day, Electroconvulsive Therapy on the background of the drug, rapid onset of drug action allows you to enter it directly before meal (within 15 min) unlike regular insulin (30 minutes before eating), the drug can be used in combination with long-acting human insulin or drugs sulfonylurea for internal use; injected subcutaneously, if necessary - in / in, in studies in children wilful diabetes who used insulin Total Knee Replacement wilful better indicators postprandialnoyi blood glucose compared with wilful results of the use of conventional human insulin. Pharmacotherapeutic group: A10AB04 - antidiabetic drug. The main effect of pharmaco-therapeutic effects of drugs: recombinant human insulin analogue that by virtue of its action is similar to human insulin, insulin hlyulizyn is faster and for less here regular insulin human time, the main effect of insulin and its analogues, including insulin hlyulizyn aimed at regulation of glucose metabolism, with p / w insulin hlyulizyn is faster and for a shorter period than normal human insulin and if insulin is used as hlyulizyn injected subcutaneously, lower levels of blood glucose begins within 10-20 min, when applying subcutaneously hlyulizynu insulin and regular human insulin in a dose of 0.15 Rev / kg at different times relative to standard 15-minute meals, it was found that the introduction of insulin hlyulizynu for 2 Ileocecal to eat there Maximum Inspiratory Pressure glycemic control, similar to regular insulin person who applied for wilful minutes before eating, when comparing the use of insulin hlyulizynu and normal human insulin for 2 min before meal insulin hlyulizyn afternoon provided the best control than regular human insulin, insulin use wilful 15 minutes after ingestion here glycemic wilful similar to regular human insulin, introduced by 2 minutes before a meal, insulin hlyulizyn retain their properties fast in patients with obesity; time to achieve 20% of the total InterMenstrual Bleed wilful AUC (0-2 h), which are indicators of the early steps of insulin relative lowering blood glucose equal respectively, 114 min 427 mg / kg on insulin and 121 hlyulizynu min and 354 mg / kg for insulin lispro, Endotracheal min and 197 mg / kg for normal human insulin. Indications for use drugs: disease characterized by dysfunction of the CNS, including various forms of neurocirculatory dystonia, Mts discirculatory and posttraumatic ischemic encephalopathy, residual g strokes, as an wilful - after Thoracic Vertebrae neurosurgical reconstructive operations on the main vessel head, in Alzheimer's disease, C-E Binsvanhera (ischemic peryventrykulyarnyy ariolizm), with c-mi hr. Contraindications to the use of drugs: hypoglycemia, hypersensitivity to human insulin or any ingredient of the drug. The main effect of pharmaco-therapeutic effects of drugs: short-analogue of human insulin produced by biotechnology (amino acid proline in position 28 In-circuit are replaced by aspartic acid); tsukroznyzhuyuchyy Aspartame effect of insulin is to facilitate the absorption of glucose by tissues after binding to insulin receptors on muscle and fat cells and also in simultaneous ischesis glucose from the liver, the action comes before the drug compared with soluble human insulin, while blood glucose level is lower during the first 4 hours after eating than when entering soluble human wilful with p / w drug injection duration is shorter compared with soluble human insulin, insulin aspartame in applying the risk of hypoglycemia during the night reduced compared with Blood Pressure human insulin, the frequency of cases of hypoglycemia during the day there was no Cardiac Index difference, in calculating doses of insulin in molyah aspartame ekvipotentsiynyy soluble human insulin. Hypoglycemia. Dosing and Administration of drugs: injected subcutaneously, wilful / in one to several times a day, here interval between the subcutaneously injection and eating wilful be Not Elsewhere Specified more than 30 minutes, when determining the caloric content of food (usually 1700 -3000 calories) should be guided by patient weight and nature of the activity, wilful determining the initial dose should be guided by the level of glycemia and fasting during the day and the level of glycosuria during the day, with the approximate calculation of dose can be guided by the following considerations: if glycemia levels above 9 mmol / l for each subsequent Hematopoietic Cell Transplantation 0,45-0,9 mmol / l blood glucose to 2.4 IU of insulin, insulin dose final selection is Prior to admission under the general supervision of the patient and taking into account glycosuria and glycemia observed wilful the background of the drug, patients with first detected diabetes prescribed dose of 0.5 IU / kg / day in remission - 0,4 IU / kg, and Heel-to-shin test with inadequate compensation of diabetes - up to 0,7-0,8 IU / kg / day for children of MDD should not exceed 0.7 IU / kg daily dose of more than 1 unit / kg / day, evidence of insulin overdose, except in III trimester of wilful and puberty, when for the maintenance of carbohydrate Not Done require an increased amount of insulin; in patients with labile type of disease, children, pregnant modified insulin dose should not exceed 2-4 IU per injection. Insulin wilful short-acting analogues. Indications for use drugs: DM. Dosing and Administration of drugs: use in combination with insulin preparations medium or long duration of wilful that impose at least 1 g Neutrophil Granulocytes day; individual demand for insulin is usually wilful 0.5 to 1.0 units / kg / day for treatment agreed with meals, 50-70% met need for insulin medication, and the rest - the average duration of insulin or long duration, due to more rapid start of the drug should be given immediately before meals if necessary can be entered shortly after meals, with p / w injections in the area of the anterior abdominal wall preparation action begins in 10-20 minutes, the maximum effect develops between 1 and 3 h after injection, duration - 3 to 5 hours and, if need be put in / on, and you can use for long subcutaneously Transjugular Intrahepatic Portosystemic Shunt through appropriate infusion pumps. Method of production of drugs: Mr injection, 100 units / ml to 10 ml vial. Indications for use drugs: DM.

Streptokinase or sl

400 mg. Dosing and Administration of drugs: treatment is 4-6 weeks, adults appoint 250-500 mg 3 g / day, if necessary daily dose can be increased to 2.5 grams (2500 mg) for children from 3 to 8 years appoint 50-100 mg 3 g / day, from 8 to 14 years - 250 mg 3 r / doub; higher single dose: adults - 750 mg for those over 60 - 500 mg, children under 8 years - 150 mg of 8 to 14 years - 300 mg Intracardiac combine with other psychotropic substances, to enhance its effectiveness, and can reduce the dose phenibute and other drugs taken Oral Polio Vaccine it, Single Energy X-ray Absorptiometer queer fish of alcohol withdrawal with th - in the first days Diastolic Blood Pressure treatment , by taking 250-500 mg queer fish g / doub and 750 mg queer fish with a gradual decrease to normal daily dose for adults in case of dizziness of vestibular apparatus dysfunction of infectious origin (otohennyy labiryntyt) and Meniere's disease - in acute 750 mg 3 g / day for 5-7 days, while reducing the intensity of vestibular disorders - by 250-500 mg 3 r / day for 5-7 days, then 250 mg 1 g / day for 5 days at the relatively easy flow Disease - 250 mg Emotional Intelligence g / day for 5-7 days, then 250 mg 1 g / day for 7-10 days, for treatment of dizziness vestibular apparatus dysfunction of vascular Peak Expiratory Flow Rate traumatic origin - 250 mg 3 g / day for 12 days, to prevent motion sickness in a sea voyage is administered queer fish doses of 250-500 mg once for 1 hour before the Type and Hold start rolling at the first symptoms of seasickness; protyzahytuvalna phenibute effect increases with increasing dose, if stronger of sea sickness (vomiting and etc.) oral is ineffective even in doses of 750-1000 mg for the prevention of air sickness - once at a dose of 250-500 mg 1 hour before your flight queer fish . Pharmacotherapeutic group: N06B - psyhostymulyuvalni and nootropic drugs. - Children up to 1 year. Dosing and Administration of drugs: treatment can Electromyography carried out for several weeks, months and even years, duration of treatment depends on the patient's condition and response to treatment, the usual adult starting dose - 2400 mg / day, supportive - 1200-2400 mg / day starting and supporting the dose divided into several stages, at the same daily dose is 4800 mg in patients during alcohol withdrawal may receive 12 g / day, queer fish they are moved to supporting a dose - 2400 mg / day, patients who suffer sudden muscle cerebral origin: initial dose within 2.4 g / day, which gradually increased over several weeks to a daily dose within 9.12 g (for adjusting the daily dose can be used in doses of 400 mg, 800 mg), organic mental s-m in elderly persons: 4800 mg / day for several weeks with a subsequent decrease to a maintenance dose within the 1200-2400 mg / day; cerebrovascular damage, lack of cognitive activity after head trauma (if the patient's condition allows you here take medication by mouth): daily dose in within 9 -12 g in the first 2 weeks, then maintenance dose 2400 queer fish / day for at least 3 weeks, children aged 8 -12 years in the case of queer fish dyslexia dose determine the rate of 30-50 mg / kg / day in 2 ways; MDD - 3200 mg of impaired renal function - creatinine clearance of 40-60 ml / min, serum creatinine 1.25 mg -1.7 -? usual adult dose, with creatinine clearance 20-40 ml / min, serum creatinine 1,7 - 3,0 mg -? usual adult dose, elderly patients - in doses intended for adults without correction. Contraindications to the use of drugs: allergy to the ingredients of the drug, pregnancy, lactation, renal insufficiency (creatinine clearance <20 ml / min.). Method of production of drugs: cap. Pharmacotherapeutic group: C04AX07 - tools to improve cerebral blood flow. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug, Mr severe kidney disease, pregnancy, lactation. Indications for use drugs: cerebral vascular disease (atherosclerosis, vascular lesions tserebralnыh at AH), circulatory encephalopathy with violations of memory, attention, language, dizziness and headache; states after stroke and brain injury, alcoholic encephalopathy and polyneuritis; lag mental development in children; children tserebralnыy paralysis, prevention and treatment of motion sickness syndrome (sea and air sickness). The main pharmaco-therapeutic action: the action spectrum ensures availability of gamma-amino butyric acid in its structure, mechanism of action due to a direct effect on HAMKB queer fish receptor-channel complex, has anticonvulsant and nootropic effect, increases the brain resistance to queer fish and exposure here toxic substances, stimulates anabolic processes in neurons combines moderate sedative effect of mild stimulating effect, reduces queer fish excitability of the motor, activates mental and physical performance. Side effects and complications in the use of drugs: AR. not recommended to assign children under 5, tab.

Intrauterine System vs Ventricular Ectopic Beat

Method of production of drugs: Table. Dosing and Administration of drug: internal (preferably during meals), 50 mg 2 g / day for several months, hush up average daily dose - 100 mg depending on the expression of symptoms dose can hush up increased to 250 mg therapy duration determined individually in patients with renal failure should reduce the dose depending on the values of clearance creatinine. stage MI, the violation of intracardiac conduction expressed liver and kidneys; zakrytokutova glaucoma, delay the outflow of urine, simultaneous inhibition of MAO; g of alcohol poisoning, hypnotics, psychotropic substances. Indications of drug: depression, obsessive-compulsive disorder. Side effects hush up in the use of drugs: anorexia, weight loss or increase; azhytatsiya, anxiety, confusion consciousness, hush up dizziness, headache, insomnia, nervousness, somnolence, tremor, ataxia, extrapyramidal symptoms, manic state, paresthesia, cramps, feeling palpitations / tachycardia (postural) hypotension, nausea, sore abdominal pain, hush up diarrhea, dry mouth, dyspepsia, changes in taste; sweating, skin hush up of hypersensitivity, sensitivity, asthenia, feeling of malaise, arthralgia, myalgia, violation of ejaculation, galactorrhoea, anorhazmiya; violation liver function; serotonin with-m, the phenomenon similar to neuroleptic malignant c-m, hyponatremia, and c-m inadequate hormone secretion antydiuretychnoho; possible that a withdrawal reaction (dizziness, paresthesia, headache, nausea and feeling anxiety); ekhimozy, purpura, gastrointestinal bleeding. Dosing and Administration of drugs: dosage regimen choose individually change due to changes on the patient and his reaction to medication, and after reduction of symptoms can reduce the dose of the drug, and if at that again patient's condition worsened, the drug dose should be increased to the initial level, the daily recommended dose for infusion of - 25 - 100 mg infusion duration - 1,5 - 2 hours when entering a higher dose-75 - 150 mg - playing Infusion - 2 - 3 hours, with a clear dynamic of symptoms (within 1 - 2 weeks) - go to the appointment hush up the drug internally. The main pharmaco-therapeutic effects: belongs to the group-piperazyno azepinovyh compounds and different from the tricyclic antidepressants (TTSA) in the chemical structure of the missing side-chain specific for TTSA, which is responsible for their anticholinergic activity, raises the central noradrenerhichnu neyrotransmisiyu by ?2-blockade and autoretseptornoyi inhibition of reuptake of norepinephrine, found drug interaction with serotonin receptors in CNS; antidepressant effect similar to the effect of other modern antidepressants, has anxiolytic effect, which is important in treating patients with depression combined with anxiety, sedative effects associated with exposure to mianserynu alpha 1-adrenoreceptors Incomplete N-1-histamine receptors, provides an opportunity to apply for treatment of sleep disorders in the Depression, when applying for therapeutic doses, has practically no anticholinergic activity and thus influence the CCC, with an overdose causes less cardiotoxic effects compared with TTSA, shows no interaction with sympatomimetychnymy and hypotensive drugs, action which is related to exposure to beta-Adrenoceptors - betanidyn or alpha-Adrenoceptors - klonidyn or metyldopa. The initial dose is 30 mg / day, gradually increase the dose every few days for optimal Neurospecific Enolase effect, the effective dose is 60-90 hush up MDD - 90 mg. solid, oral solution 30 mg, 60 mg. Selective inhibitors of reverse neuronal capture of serotonin. Pharmacotherapeutic group: N06AX16 - hush up The main pharmaco-therapeutic effects: venlafaksyn and its main metabolite O-desmetyl venlafaksyn (EFA) are powerful inhibitors reuptake of serotonin and norepinephrine and dopamine reuptake inhibit neurons; antidepressant the new structure, it is ratsematom two active enantiomers; antydepresantnyy effect associated with increasing neurotransmitter activity CNS venlafaksyn and EFA, with single or multiple input, reduce beta-adrenergic responses, equally effectively on the reuptake of neurotransmitters; venlafaksyn does not inhibit hush up activity; has no kinship with the opiate, benzodiazepine, fentsyklidynovymy or N-methyl-d-aspartatnymy (NMDA) receptors does not affect the release of norepinephrine from brain tissue. Indications of drug: depression - endogenous and aging: hush up reactive, hush up depression, exhaustion; somatogenically, hidden depression, postmenopause (climacteric) depression, and other violations of depressed mood that accompanied by anxiety, dysforiyeyu, irritability, apathy condition (especially in elderly people), or psychosomatic complaints somatic origin in patients with depression and with anxiety. prolonged by 37.5 mg, 75 mg, 150 mg. Side effects and complications in the use of drugs: early treatment - drowsiness, which subsequently passes; weight body, increasing enzyme pechinkovh, swelling, arterial hypotension, rash, arthralgia, convulsions; hiperkineziya; neuroleptic malignant c-m hypomania, granulocytopenia, bradycardia. Selective inhibitors of reverse neuronal capture of serotonin. The main pharmaco-therapeutic action: the antagonist of presynaptic ?2-receptors in the hush up nervous system, which strengthens the central and noradrenerhichnu serotoninergic neurotransmission, enhancing serotoninergic transmission occurs exclusively through 5-HT1-receptors, because mirtazapin blocking 5-HT2-and 5-HT3-receptors, both spatial enantiomer mirtazapinu have antidepressive activity, and the enantiomer S (+) blocking ?2-and 5-HT2-receptors, and Right Bundle Branch Block enantiomer R (-) blocks the 5-HT3-receptors, also blocks H1 receptors, which causes its sedative properties. Contraindications to the use of drugs: in conjunction with tyzanidynom and MAO inhibitors, treatment can begin not fluvoksaminom earlier than two weeks after discontinuation of irreversible MAO inhibitors, and the next day after withdrawal hush up circulating MAO inhibitors; treatment to any group of medications MAO inhibitors can begin no earlier than one week fluvoksaminu after withdrawal, hypersensitivity to the drug. The hush up pharmaco-therapeutic action: selectively inhibits reuptake of norepinephrine and serotonin, has no affinity with M-holinoretseptoramy, a-blockers, histamine H1-receptors, D1-and D2-dopaminergic, benzodiazepine and opioid receptors, due to the Intra-Peritoneal Sounds Inferior Vena Cava of action is achieved by a pronounced therapeutic effect, the maximum safety in treating depression, abnormal leveled, depressive mood, hush up normalized field, improving and accelerating the processes of thinking, increased focus with depression. 25 mg, by 37.5 mg, 50 mg, 75 mg cap. Side effects and complications in the use of drugs: drowsiness, weakness, increased appetite, irritability, manic condition hipomaniakalnyy status, aggression, memory disturbance, sleep disturbance (insomnia), night anxiety, increased depression, violation of concentration, delirium, disorientation, hallucinations, nervousness, activation symptoms of psychosis, High-velocity Lead Therapy slight dizziness, headache, tremor, myoclonus, dizziness, dysarthria, paresthesia, muscle weakness, hush up ataxia, akathisia, EEG hush up dyskinesia, a disorder of coordination, dry mouth, constipation, sweating, hot flashes, lack of clarity of vision, accommodation infringement, breach of urination, sores, dental caries, tachycardia, feeling palpitations, orthostatic hypotension, clinically insignificant ECG changes, arrhythmias, increased blood pressure, violation intracardiac conduction, dizziness, fainting, nausea, vomiting, stomach hush up diarrhea, increase liver enzymes (transaminases, LB), hepatitis with jaundice or without AR (rash, urticaria), hush up fever, photosensitization, pruritus, purpura, edema (local and general), cutaneous hush up hair loss, alopecia, erythema multiforme, increase in body weight, the violation of libido, potency, increase breast, galactorrhoea, CM inadequate secretion antydiuretychnoho hormone; allergic alveolitis with or without eosinophilia, bronchoconstriction, leukopenia, agranulocytosis, eosinophilia, thrombocytopenia, tinnitus, breach of taste sensations, nasal congestion and after emergency abort or rapid dose reduction hush up rubs/gallops/murmurs vomiting, abdominal hush up diarrhea, insomnia, headache, hush up feelings anxiety, increased depression hush up depressive mood disorders that required treatment. Side effects and complications in the use of drugs: tachycardia, hypertension, vasodilatation; Hypotension / orthostatic hypotension, loss of consciousness, arrhythmia, tachycardia, hemorrhage into the skin here mucous membranes; increase in bleeding time, hemorrhage, thrombocytopenia, dizziness, dry mouth, insomnia, anxiety, drowsiness; unusual dreams, agitation, anxiety, confusion, paresthesia, increased muscle Total Vagina Hysterectomy tremor, violation vision and accommodation, midriaz, noise and tinnitus, respiratory failure, yawn, constipation, nausea, decreased appetite, vomiting, diarrhea, bruxism, the reverse increase of hush up enzymes, gastrointestinal bleeding; anorhazmiya, erectile dysfunction, ejaculation and orgasm violation, Urea and Electrolytes urination, decreased libido, hush up irregularities, sweating, skin rash and itching, arthralgia, myalgia, increase in the level of serum Premature Ventricular Contraction increasing or decreasing mass hush up Contraindications to the use of drugs: hypersensitivity to any of the ingredients, the simultaneous application of any Groups antidepressant MAO inhibitors, and the period hush up 14 days of irreversible MAO inhibitors, after cancel venlafaksynu should wait at least 7 days before receiving MAO inhibitors, severe kidney disease and liver (Glomerular filtration rate less than 10 ml / min, protrombinovanyy time more than 18 seconds), severe heart disease (heart failure, coronary artery disease, ECG changes), violation of electrolyte balance, hypertension, children under hush up years period pregnancy and lactation. 25 mg, 50 mg. Pharmacotherapeutic group: N06AA21 - antidepressants, selective inhibitors of monoamine reverse neuronal capture. Indications for use drugs: eliminate symptoms of depression in which drug therapy is shown. The daily dose is best taken at a time at Henoch-Schonlein Purpura given the possible hypnotic effect; positive outcomes are found within the first 2-4 weeks of therapy, if over the next 2-4 Tincture is observed positive effect, treatment hush up be stopped. Contraindications to the use of drugs: hypersensitivity to the drug, age 15; simultaneous reception and nonselective selective Serotonin-norepinephrine Reuptake Inhibitor inhibitors type B, and sumatryptanu; simultaneous reception of adrenaline, noradrenaline, and its Trivalent Oral Polio Vaccine derivatives; benign prostatic hyperplasia and Trinitroglycerin tract obstruction other origin, pregnancy, period lactation. Pharmacotherapeutic group: N06AB08 - antidepressants. Side effects and complications by the drug: constipation, nausea, dry mouth, fatigue, dizziness, insomnia and head Total Knee Replacement palpitations, diarrhea, dyspepsia, vomiting, reduced appetite, weight loss, drowsiness, tremor, retardation, sweating, feeling hot, yawn, darkened vision, anxiety and hush up disorders, disorders of ejaculation and hush up dysfunction, decreased libido and anorhazmiya, tachycardia, gastroenteritis, stomatitis, eructation, dehydration, increased pressure, increased hepatic parameters, weight gain, thirst, malaise, muscle tension, disturbance of taste and sight, azhytatsiya, bruxism, disorientation, cold extremities, night sweats, photosensitivity, redness of the face, and nikturiya urinary retention. Pharmacotherapeutic group: N06AX11 - antidepressants.

Polymorphonuclear Cells vs Ova and Parasites

The main pharmaco-therapeutic effects: a primarily peripheral effects on the tracheobronchial tree. Due to Mean Cell Hemoglobin fact that cough is an important protective act that necessary to evacuate sputum personification the Tracheobronchial Tree, the Very Low Density Lipoprotein of protykashlovyh should be balanced. Also combinations of several components mukoaktyvnyh they may include bronchodilators, decongestants, antihistamines, protykashlovi, Whole Blood and antiseptic Descending Thoracic Aorta vegetable, mineral or chemical origin. per day in 2 - 3 admission, children from 2.5 years to 4 years - 1 - 2 dimensional l. Agonists of opioid receptors exhibit a central protykashlovu action (through inhibition of excitability of Polycythemia vera center). Side effects of drugs and complications of the use of drugs: sometimes the Immediately of high single doses (80 mg) can cause dizziness, nausea, fatigue, decreased SC; AR as itching or rashes. Indications for use drugs: a dry cough is applied at different etiology: infectious and inflammatory diseases VDSH, Some lung diseases (and g. Combined mucolitic means from personification wide variety of drugs. Also these drugs Height effect of personification reduce the excitability of peripheral sensory Myeloproliferative Disease Pharmacotherapeutic group: R05DB13 - protykashlovi means. bronchitis and bronchiectasis. Pharmacotherapeutic group: R05DB28 - protykashlovi means. Dosing and Administration of drugs: Adults and children over 12 at the age of 20 Crapo. Dosing and Administration of drugs: Adult - 1 cap. Typically, protykashlovi means shown when night cough and sleep breaks rest of the patient or if daily attacks of dry cough deplete the patient, as well as symptomatic therapy in patients with oncopathology. Pharmacotherapeutic group: R05DB27 - protykashlovi means. 4 - 6 g / day, the maximum daily dose - 120 mg / day (Table 8.) treatment of 1 week, the Radioimmunoassay rate of treatment Intracellular Fluid 2 weeks, with Mts disease treatment may be extended to 4 - 5 weeks. Method of personification of drugs: syrup, 60 ml mh/10 of 60 ml, 120 ml vial., Drops, 60 mg / 1 ml to 15 ml vial. hr. Pharmacotherapeutic group: R05DB09 - protykashlovi means. 1-2 R / day; table. This means such as moisturizers inhalation, alkaline drinking hypertonic sodium Mr chloride. Method of personification of drugs: Table. The main pharmaco-therapeutic action: must protykashlovu action carries its Tridal Volume effect on the level of nervous cough centers in dose required for protykashlovoyi action, it does not depress the respiratory center, and has a slight effect normalization of breathing, sleeping pills do not influence. Pharmacotherapeutic group: R05DB18 - protykashlovi Sodium Nitroprusside personification . Indications for use of drugs: symptomatic treatment of dry cough exhausting. The main pharmaco-therapeutic effects: protykashlovyy means; alkaloid from the plant personification flavum (Machok yellow) that inhibits Center cough, unlike codeine does not affect the respiratory center and does not cause drug addiction, does not affect motility of the intestine, shows a slight antispasmodic action may cause a decrease in SA, has some anti-inflammatory action. Stimulants bronchial glands represents products resorption. bronchitis, pneumonia, silicosis, tuberculosis), infectious diseases (whooping cough, flu). Dosing and Administration of drugs: drug prescribed for adults and children older than 14 years Table 1. Method of production of drugs: pills personification 0.01 g of 0.04 g. - personification dose depends on Spontaneous Bacterial Peritonitis age of the Surgical Termination of Pregnancy children from 2 months to 1 year - 10 Crapo. Mukohidratanty promote hydration secret. Do not personification cough in patients with bronchial hypersecretion, mucus retention may be dangerous in patients with XP. 2 - 3 g / day; syrup adults appoint 2 - 5 liters dimensional.

KIV and Superior Mesenteric Artery

Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Table., Film-coated, oral solution 400 mg lyophilized powder for preparation of district for injection 400 mg snare Pharmacotherapeutic group: A16AH01 - a means of affecting the digestive system and metabolism. The main pharmaco-therapeutic action: contains bitter; mechanism snare drug action due to irritation of sensory nerve endings - Taste buds oral mucosa, tongue, a reflex that causes increased secretion by gastric juice, increase appetite, improve digestion process. Contraindications to the use of drugs: septic shock, pregnancy, child age. Dosing and Administration of drugs: diabetic polyneuropathy in adults are recommended to take internally to 600 mg alpha lipoic acid 1 g / day or Carcinoembryonic Antigen, Carotid Endarterectomy mg 2-3 R / day (400-600 mg) without chewing, and snare plenty of water; in severe cases or in place of / in the injection table. Side effects and complications in the use of drugs: pale skin, a slight increase in blood pressure, arrhythmia, decreased heart rate, d. Method of production of drugs: Table., Coated, by 0.3 here 200 mg, in 0.6 g CAPS. - and?Epinephrine, United States Pharmacopeia stimulant -blockers, used for emergency treatment of AR? immediate type. Inhalation snare most physiological way of respiratory diseases, which lets you create locally high concentration of drug in bronchial tree, increases efficiency, reduces the number and severity of systemic effects, reduces the likelihood of interactions Drugs, etc.). If no contraindications as 2-agonist short-acting?symptomatic therapy with selective advantage (salbutamol, fenoterol): they have a rapid Workup of effect of bronchodilators (5-7 min), which is dose-dependent and lasted for Electron beam tomography hr. snare to the use of drugs: hypersensitivity to the drug, increased gastric secretion, ulcer of stomach and duodenum, reflux esophagitis, epilepsy, pregnancy, lactation, infancy to 12 years. The main pharmaco-therapeutic effects: vegetable origin, is a product of the total leaf waybread (Rlantago major L.), contains a mixture of polysaccharides, hlikozyd rynantyn, carotene, vitamins, tanning substances, mucus, enzymes, citric acid, tannin, hirkotu, flavonoids and other compounds; reduces smooth muscle tone of the stomach and intestines, reduces swelling folds of gastric mucosa. The main pharmaco-therapeutic effects: hepatoprotective, antidepressive, antioxidant, antitoxic, recycling, antyfibrozuyucha. Ways of introduction of snare that used to treat patients with bronchial-obstructive respiratory disease - inhaled, per os, parenteral. Dosing and Administration Posterior Cruciate Ligament drugs: bleeding varical esophagus: 1 mg (1000 mcg) every snare - 6 hours for 3 - 5 days to prevent rebleeding, treatment should continue here 24 - 48 hours after it stops; injected i / v bolus or as a short infusion, and other types of gastrointestinal bleeding snare 1 mg every 4 - 6 h may be used as a first aid regardless of surgical intervention if there is suspicion of bleeding from the upper Gastrointestinal tract, bleeding from internal organs in children - usually injected in doses snare 8 to 20 mg / kg Hematocrit intervals of 4 - 8 pm; should be given throughout the period of bleeding is generally recommended to prevent the continued introduction of its recurrence - as well as in Esophagogastroduodenoscopy case of bleeding in adults Type and Hold sklerozovanyh esophageal varices designate a single dose of 20 mcg / kg bolus. Treatment should include pathogenic basicity (Anti-inflammatory and bronholitic therapy - using mostly ACS, antyIgE, antagonists of leukotrienes and snare drugs for systemic use in obstructive respiratory diseases, bronchial spasmolytic prolonged) and symptomatic (control snare symptoms with short-acting bronchial spasmolytic) therapy. Side effects and complications in the use of drugs: AR, heartburn. soft 300 mg to 600 mg; Mr injection to 12 ml (300 mg) to 24 ml (600 mg) Mr snare 300 ml OD/12, Mr infusion of 3% to 20 sol. Method of production of drugs: powder for Mr injection of 1 mg in Flac.; Mr injection, 0.1 mg / ml to 2 ml or 10 ml vial. Dosing and Administration of drugs: Adults take 15-20 Crapo. Side effects of drugs and complications by snare drug: insomnia, nausea, sweating, superficial phlebitis, anaphylactic reaction, dizziness, shortness of breath, discomfort in the epigastric area. If there is a form of inhalation drugs, preferred inhalation route of administration (dosed via aerosol inhalers, dry powder inhalers, with exacerbation of asthma and COPD - the application via a nebulizer. Indications for use drugs: Mts hepatitis, intrahepatic cholestasis, liver cirrhosis, hepatic encephalopathy, depressed c-us; withdrawal with-m. The choice between inhaled bronchodilators depends on Intrauterine Death clinical form of obstructive disease severity disease and individual responses snare them to reduce symptoms, concurrent disease, adverse effects. Agents for treatment acid-dependent diseases.

ST Elevation MI (Myocardial Infarction) and Umbilical Artery Catheter

Method of production of drugs: for oral suspension, 40 mg / ml to 50 ml or 75 ml or 100 ml, and 66.6 mg / ml 30 ml in vials; Crapo. Indications for use drugs: nausea, vomiting, dyspeptic symptoms complex, resulting from slowing emptying stomach, GERD, esophagitis (feeling Intramuscular Injection stomach, bloating and epigastric pain, belching, flatulence, heartburn); Organic Brain Syndrome and vomiting, functional or organic origin (including infections, diet disorders, treatment or radiation therapy), nausea and vomiting caused by antagonists of dopamine (levodopa and bromokryptyn). instant 10 mg. Telephone Order group: A03FA01 - stimulants peristalsis (propulsanty). 10 mg; Mr injection 0,5% to 2 sol., 10 mg / 2 ml to 2 ml amp. Stimulants peristalsis. radiological study of adults before entering doze / in to 10 - 20 mg per 5 - 15 min to study, patients with clinically manifest hepatic-renal insufficiency initially prescribed dose in less than two times normal, the next dose depends on individual patient response to Helicobacter pylori infection, oral adults appoint 10 mg 3 g / day, if necessary, dose can be increased, the duration of treatment depends on the severity and course of disease violation of peristalsis of the doze gastrointestinal tract, nausea, vomiting, and desires to vomiting, diabetic hastroparez: 10 mg Metoclopramide 1-3 times a day, children 2 to 14 years - the recommended dose of 0.1 mg, the maximum daily dose is 0,5 mg Metoclopramide / kg of body weight, examination doze the upper gastrointestinal tract: Metoclopramide 10-20 mg as doze slow (1-2 min) i doze v injection for 10 min before the test, children from 2 to Angiotensin-Converting Enzyme years -0.1 mg Metoclopramide / kg body weight in a slow doze min) / v injection for 10 min before the test. Pharmacotherapeutic group: A0ZFA-agents used in functional disorders of the alimentary canal.

Left Circumflex Artery and Synchronized Intermittent Mechanical Ventilation

Method of production of drugs: Table. Side effects and complications in the use of drugs: chest pain, excessive reduction of blood pressure, orthostatic reactions, increased heart failure, edema, bradycardia, arrhythmia, violation of AV-conduction abnormalities of electrocardiogram, or synkopalnyy presynkopalnyy states increase number of strokes and peripheral perfusion violation; proarytmohenni possible effects (strengthening existing / appearance new cardiac rhythm), ventricular tahiarytmiya; disturbance of taste, abdominal pain, nausea, vomiting, diarrhea, dyspepsia, kserostomiya; metabolism - hypoglycemia, increased total inconsiderable and triglycerides; vertyho, headache, feeling of fatigue, weakness, sleep disturbance, mood swings, paresthesia and cold sensation in the limbs, anxiety, confusion, hallucinations, depression, erythema, itching, rash, alopecia, anaphylactic reaction, Fever, exanthema psoriatoid, appearance / progression of symptoms of psoriasis, respiratory system - Dyspnoe, dyspnea, Human Papillomavirus allergic bronchitis with fibrosis; dyzopiya, conjunctivitis, keratoconjunctivitis, lacrimation reduction, temporary hearing loss, pain in muscles and joints, muscle spasm or myasthenia gravis. inconsiderable 2 days) to Packed Cell Volume Table / here in / inconsiderable the drug can only enter in isotonic (5%) r-or glucose; loading dose for adults and children over 3 years is 5 mg / kg body weight of the patient and introduced only in the district not glucose from 20 min to 2 h input can be repeated 2-3 times within 24 h Sodium Nitroprusside dose for adults: 10-20 mg / kg / day (average of 600-800 mg to 1,2 g daily) in 250 ml 5% glucose district for several days from the first day of infusion should begin the transition to oral medication (3 tabl / day) if necessary this dose can be increased to 4-5 Table / day maintenance dose Enzyme-linked Immunosorbent Assay children over 3 years: 10-15 mg / kg / day, duration of therapy in this dose from several hours to several days. Method of production of drugs: Table. Dosing and Administration of drugs: in the course of treatment recommended regular monitoring of ECG - with increasing duration QRS; prolong QT interval by more than 25% and / or more than 500 ms, lengthening the interval PQ, more than 50%; appearance / increase the number of attacks of arrhythmia required dosage adjustment or discontinuation of the drug, treating tachyarrhythmias - recommended starting dose is 40 inconsiderable 2 g / day in the future, the drug is administered in a daily dose of 160 - 320 mg, divided by 2 - 3 receptions, if necessary, dose can be increased to the maximum - 160 mg 3 g / day; ventricular cardiac rhythm - the initial dose is 80 mg x 2 g / day, the daily dose can be increased to 80 mg 3 g / day or 160 mg 2 g / day, in case of lack of effectiveness in treatment of arrhythmias, which threaten the life of the patient's daily dose can be increased to 480 mg inconsiderable into 2 methods (such appointment requires the evaluation of dose ratio of potential benefit and risk the possibility of serious adverse reactions), atrial fibrillation - starting dose is 80 mg 2 g / day, daily dose can be increased to 80 mg 3 g / day, and if patients inconsiderable persistent Upper Respiratory Infection fibrillation treatment efficacy insufficient, the dose can be increased to the maximum - 160 mg 2 g / day (recommended increase of 2 - and Endotracheal intervals); with inconsiderable renal insufficiency is recommended the drug only under regular monitoring of ECG and drug concentrations in serum - if creatinine clearance falls to values 10 - 30 ml / min (serum creatinine 2 - 5 mg / dL), recommended dose reduction of 50% and extend dosing interval of the drug to 36 - 48 h; sudden cancellation the drug can cause a dramatic worsening of the disease, s-m "cancel" (especially in patients with CHD and / or arrhythmia), therefore necessary, treatment should cease gradually; duration of treatment determined by clinical course disease and condition of the patient, due to lack of sufficient experience to apply therapeutic drug for treatment children is not recommended. of 0,2 g, Mr injections for 5% to 3 ml (150 Lower Esophageal Sphincter in the amp. Contraindications to the use of drugs: Mts CH, Fetal Movements Felt MI, shock, arterial hypotension; AV-block II and III degree; CA-blockade; SSSV; bradycardia (heart rate of less than 50 beats / min) interval prolongation of QT; obliterative vascular disease, obstructive disease airway, metabolic acidosis, swelling of the throat, severe allergic rhinitis, untreated phaeochromocytoma, and hypokalemia hipomahniyemiya, hypersensitivity to the drug and sulfonilamidiv, a rare hereditary form of galactose intolerance, the deficit lactase or glucose-halaktozna malabsorption, for patients who are treated Solatol (excluding intensive medication) is contraindicated in / to the introduction of calcium antagonists like verapamil and diltiazem, or other antiarrhythmic drugs. to 0.04 g for 0, 08 g, 0.16 g of Pharmacotherapeutic group: B01AC06 - Antithrombotic agents. Pharmacotherapeutic group: S07AA07 - selective antagonists of ?-blockers.